Is the Incidence of Multiple Malignancies among Patients with Malignant Melanoma Increasing? An Eight Year Single Center Experience

  • Yamagami Yuna
    Department of Dermatology, Graduate School of Medicine, Kyoto University
  • Endo Yuichiro
    Department of Dermatology, Graduate School of Medicine, Kyoto University
  • Fujisawa Akihiro
    Department of Dermatology, Graduate School of Medicine, Kyoto University
  • Kato Mayumi
    Department of Dermatology, Graduate School of Medicine, Kyoto University
  • Tanioka Miki
    Department of Dermatology, Graduate School of Medicine, Kyoto University
  • Kabashima Kenji
    Department of Dermatology, Graduate School of Medicine, Kyoto University
  • Miyachi Yoshiki
    Department of Dermatology, Graduate School of Medicine, Kyoto University

Bibliographic Information

Other Title
  • 悪性黒色腫の重複がんは増加しているのか?:大学病院での8年間(2005~2012年)の統計から
  • アクセイ コクショク シュ ノ チョウフク ガン ワ ゾウカ シテ イル ノ カ? : ダイガク ビョウイン デ ノ 8ネンカン(2005~2012ネン)ノ トウケイ カラ

Search this article

Description

The incidence of multiple malignancies among patients with malignant melanoma (MM) is 4.8%in Japan and has reportedly been as low as that of other skin cancers, although little has been known about the exact incidence. However, compared with other reports, the incidence of multiple malignancies seemed to be higher among patients with MM than among those with other malignancies in our hospital. Therefore, we performed an observational study to explore the incidence of multiple malignancies among the 130 patients with MM who were treated at our hospital from 2005 to 2012. Twenty (seven males and 13 females) out of the 130 patients with MM (15.4%) were treated in our facility for multiple malignancies. Fifteen cases (five males, 10 females) had double malignancies including MM; five (two males, three females) had triple malignancies. Of these twenty patients, fifteen (five males, 10 females) had malignancies preceding the MM, two (two females) had concurrent malignancies, and four (two males, two females) had subsequent malignancies. Four of the six patients who had concurrent malignancies developed subsequent malignancies within one year of the initial diagnosis, and two patients developed the second malignancy within five years. Therefore, it is important not only to check for the recurrence and metastasis of MM, but also to regularly and carefully follow up MM patients, because they appear to have a higher risk for other malignant tumors.

Journal

Details 詳細情報について

Report a problem

Back to top